Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis (Q38295438)

1 September 2017

0 references

1 reference

title

Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis (English)

1 reference

1 September 2017

1 reference

1 reference

1 reference

XinYuan Zhang

1

1 reference

1 September 2017

Wei Liu

2

1 reference

1 September 2017

ShanShan Wu

3

1 reference

1 September 2017

JingLong Jin

4

1 reference

1 September 2017

WeiHong Li

5

1 reference

1 September 2017

NingLi Wang

6

1 reference

1 September 2017

publication date

20 December 2014

1 reference

Science in China. Series C: Life Sciences

1 September 2017

published in

1 reference

1 September 2017

volume

58

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

101-107

1 reference

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Prevalence of diabetic retinopathy in rural China: the Handan Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Calcium dobesilate and oxerutin: effectiveness of combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Effects of calcium dobesilate on the synthesis of endothelium-dependent relaxing factors in rabbit isolated aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Calcium dobesilate as a treatment for capillary fragility in diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Differential Association of Serum Lipids with Diabetic Retinopathy and Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Association of serum lipids with diabetic retinopathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Generation of allocation sequences in randomised trials: chance, not choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

When are randomised trials unnecessary? Picking signal from noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

Reporting of sample size calculation in randomised controlled trials: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11427-014-4792-1

10.1007/S11427-014-4792-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1003876417

0 references

Fatcat ID

release_ra4k3qlsgna7zmbsccocyuz4ie

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ra4k3qlsgna7zmbsccocyuz4ie

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference